We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
FLSM
1
Frazier Life Sciences Management
California
$3.37M
TCM
2
Tang Capital Management
California
$2.68M
FCM
3
Farallon Capital Management
California
$1.98M
BlackRock
4
BlackRock
New York
$1.78M +$152K +258,009 +9%
BI
5
BVF Inc
California
$1.67M
ACM
6
Aisling Capital Management
New York
$1.59M
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.47M -$272K -461,535 -15%
Goldman Sachs
8
Goldman Sachs
New York
$929K -$1.38M -2,336,749 -59%
Renaissance Technologies
9
Renaissance Technologies
New York
$902K -$108K -182,673 -10%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$651K +$28K +47,487 +4%
State Street
11
State Street
Massachusetts
$603K +$31.8K +53,857 +5%
SFM
12
Sphera Funds Management
Israel
$573K -$36.1K -61,200 -6%
O
13
OrbiMed
New York
$530K
Millennium Management
14
Millennium Management
New York
$459K +$18K +30,466 +4%
IC
15
Ikarian Capital
Texas
$388K -$23 -39 -0%
Ameriprise
16
Ameriprise
Minnesota
$250K +$2.1K +3,550 +0.8%
Northern Trust
17
Northern Trust
Illinois
$243K +$35.1K +59,392 +16%
AI
18
Allostery Investments
Connecticut
$243K +$255K +432,206 New
Morgan Stanley
19
Morgan Stanley
New York
$237K -$313K -530,652 -56%
SSA
20
Schonfeld Strategic Advisors
New York
$188K -$124K -210,000 -39%
Citadel Advisors
21
Citadel Advisors
Florida
$150K +$157K +266,243 New
Two Sigma Investments
22
Two Sigma Investments
New York
$121K -$20 -34 -0%
SCM
23
Stonepine Capital Management
Oregon
$113K +$118K +200,000 New
Deutsche Bank
24
Deutsche Bank
Germany
$106K +$94.3K +159,751 +550%
BFM
25
Boothbay Fund Management
New York
$103K -$23 -39 -0%